CII
ONC

Capital International Inc’s BeOne Medicines Ltd ONC Stock Holding History

Capital International Inc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.1M Buy
305,477
+3,234
+1% +$953K 0.61% 44
2026
Q1 		$89.8M Sell
302,243
-5,417
-2% -$1.75M 0.69% 37
2025
Q4 		$93.5M Sell
307,660
-18,184
-6% -$5.95M 0.74% 36
2025
Q3 		$111M Sell
325,844
-19,715
-6% -$5.99M 0.89% 28
2025
Q2 		$83.6M Sell
345,559
-91,823
-21% -$22.5M 0.81% 28
2025
Q1 		$119M Sell
437,382
-117,544
-21% -$27.5M 1.44% 12
2024
Q4 		$103M Sell
554,926
-69,969
-11% -$14.3M 1.21% 17
2024
Q3 		$140M Sell
624,895
-230,239
-27% -$41.4M 1.77% 6
2024
Q2 		$122M Sell
855,134
-3,230
-0.4% -$498K 1.62% 8
2024
Q1 		$134M Buy
858,364
+48,615
+6% +$7.83M 1.81% 5
2023
Q4 		$146M Sell
809,749
-39,482
-5% -$7.14M 2.28% 4
2023
Q3 		$153M Sell
849,231
-70,205
-8% -$13.9M 2.93% 3
2023
Q2 		$164M Sell
919,436
-77,606
-8% -$17.9M 2.98% 3
2023
Q1 		$215M Sell
997,042
-100,857
-9% -$24.2M 4.32% 1
2022
Q4 		$241M Sell
1,097,899
-30,290
-3% -$5.55M 5.21% 1
2022
Q3 		$152M Sell
1,128,189
-15,016
-1% -$2.58M 3.4% 1
2022
Q2 		$185M Buy
1,143,205
+2,245
+0.2% +$351K 2.57% 2
2022
Q1 		$215M Buy
1,140,960
+141,133
+14% +$30M 2.41% 5
2021
Q4 		$271M Sell
999,827
-12,308
-1% -$4.16M 2.52% 5
2021
Q3 		$367M Buy
1,012,135
+74,276
+8% +$24.3M 3.54% 1
2021
Q2 		$322M Sell
937,859
-98,071
-9% -$32.5M 2.87% 2
2021
Q1 		$361M Buy
1,035,930
+43,920
+4% +$14.5M 3.35% 1
2020
Q4 		$256M Sell
992,010
-106,344
-10% -$29.3M 2.38% 5
2020
Q3 		$315M Sell
1,098,354
-15,388
-1% -$3.62M 3.46% 1
2020
Q2 		$210M Buy
1,113,742
+76,470
+7% +$12.4M 2.56% 4
2020
Q1 		$128M Buy
1,037,272
+76,509
+8% +$12M 2.15% 6
2019
Q4 		$159M Sell
960,763
-6,511
-0.7% -$1.08M 2.21% 2
2019
Q3 		$118M Buy
967,274
+622,156
+180% +$82.6M 1.78% 4
2019
Q2 		$42.8M Buy
345,118
+32,128
+10% +$4.08M 2.99% 5
2019
Q1 		$41.3M Buy
312,990
+117,318
+60% +$15.8M 4.92% 4
2018
Q4 		$27.4M Buy
+195,672
New +$25.9M 3.75% 6

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Capital International Inc's ONC Position: Q2 2026 in Review

Capital International Inc increased its BeOne Medicines Ltd (ONC) stake by 1.1% in Q2 2026, buying an estimated $953K and bringing the position to 305,477 shares worth $87.1M. The position accounts for 0.61% of the portfolio, ranked #44.

Capital International Inc first reported a position in ONC in Q4 2018 and has held it in 31 quarters since. The position peaked at $367M in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Capital International Inc held 305,477 shares of BeOne Medicines Ltd worth $87.1M as of Q2 2026.
  • Capital International Inc bought 3,234 BeOne Medicines Ltd shares in Q2 2026, an estimated $953K.
  • BeOne Medicines Ltd made up 0.61% of Capital International Inc's portfolio in Q2 2026, its #44 holding.
  • Capital International Inc first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 31 quarters since.
  • Capital International Inc's BeOne Medicines Ltd position peaked at $367M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.